Customicro Clinical Services

We offer programs focused on antibiotic stewardship

Customicro's PharmD i3 Service prioritizes topical solutions to manage biofilms as a strategy to combat the biofilm's resilience that arises from multiple factors:

Physical barrier: Biofilms form a protective matrix that shields bacteria from antibiotics and the immune system.
Altered metabolism: Bacteria within biofilms can enter a slow-growing state, reducing antibiotic effectiveness.
Genetic exchange: Biofilms facilitate the transfer of resistance genes between bacteria.

Given these challenges, the topical targeting of biofilms is essential for effective infection control.

Identification

Partner microbiological laboratories perform molecular diagnostics to streamline testing and reporting of clinical samples, support rapid diagnostic testing, and provide expertise for interpretation of microbiological tests.

Interpretation

Our pharmacists are a reliable source of healthcare information, offering clinical interpretations of molecular diagnostics to support medication therapy management, screen for potential drug interactions and allergies, and educate patients on the proper use of antibiotics and expected side effects.

Intervention

Upon request from the provider, our pharmacists offer individualized recommendations for topical anti-biofilm TargetedRx Therapy. The recommendations are based on pathogenic bioburden and resistance genes identified through molecular diagnostics, as part of our comprehensive programs.

Blue rod-shaped bacteria floating on a dark background

Why target biofilms?

Targeting biofilms is crucial for effective infection management due to their role in antibiotic resistance and persistent infections. Strategies to combat biofilms include breaking down the extracellular polymeric substance (EPS) matrix to enhance antibiotic effectiveness, inhibiting their initial formation, and utilizing specialized agents designed to eliminate biofilm-associated bacteria. Addressing biofilms directly not only improves patient outcomes but also helps curb the spread of antibiotic-resistant infections.

- Sarah Simmers, PharmD

Clinical Services

Customicro Clinical Services offers our PharmD i3 Service as an intervention to address the patient's underlying infection, often present in a biofilm, and the microenvironment needing support to remove it. Our clinical services are focused on the education of our patients and providers of programs available to offer strategies to clear the difficult to treat or recurrent infection.

Service Scope: The scope of each clinical service is focused on a specific body site or condition, offering targeted support through molecular diagnostics, clinical interpretation, and pharmacist-guided recommendations.

Focused support for biofilm management in wound care.

Learn more

Personalized support for vaginal health.

Learn more

Targeted clinical support for sinus health.

Learn more

Clinical services for comprehensive nail care.

Learn more

Clinical services designed to support gut health needs.

Learn more

Practical clinical guidance for infection-related questions.

Learn more

Clinical Programs

Customicro Clinical Programs offer a comprehensive, on-going initiative to remove and prevent biofilms, treat an infection with a topical TargetedRx, and restore any imbalance to the microenvironment.

Program Scope: The scope is broader including patient and provider education, supplements, and prescription medications to both prevent and offer treatment strategies necessary for ongoing infection management and microenvironment restoration.

Biofilm management to clear an infection is the most common and preventable challenge in wound healing. The BioFACT or Wound Hygiene Program offers a systematic approach to wound chronicity management.

Learn more